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ABSTRACT
Aim: Currently a variety of different colour vision tests exist in clinical practice each with
its own merits and limitations. The Ishihara test is commonly used to test for congenital
deficiency, causing red-green deficits. However acquired deficiency is also common in
any ocular pathology affecting the optic nerve. The aim of this study is to compare the
Mollon-reffin Minimal Test (MRMT) against the Ishihara and City colour vision tests.
Methods: All three tests were performed within the same clinic visit with a small rest
between tests. The main parameters of interest were correlation levels between tests for
defect detection, severity grading and defect type classification. We assessed the time
taken to complete testing and evaluated the patients experience of test.
Results: We assessed 100 patients and 54 visually ‘normal’ subjects, with re-testing in
the latter group to evaluate test-retest reliability. We found a reasonable level of
agreement between the MRMT and the other tests once considering possible
confounders for defect detection, severity grading and defect type classification in the
patient group. There was a strong level of agreement in the visually normal group which
suggests a high specificity relative to the other tests. The time taken to perform the MRMT
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is clinically acceptable in comparison to the City Test.
Conclusions: Patients experiences of the MRMT were positive and they preferred it to
the other tests. We recommend that the MRMT be used detect colour vision defects or
monitor deficiency, in patients with a significant visual field defect.
Keywords: Colour vision; city test; Ishihara test; mollon-reffin test; diagnostic accuracy.
1. INTRODUCTION
Normal colour vision perception is dependent on the presence of healthy cone
photoreceptors in the retina and functional neural components to process a visual stimulus.
Cone photoreceptors form different sub-populations correlating with the primary colours of
red, green and blue. Each set of cones detects light within its own spectrum. The red
spectrum cones are the most abundant cell population (74%), followed by cones that detect
light in the green spectrum (16%) and finally cones which detect blue light (10%). The terms
protan (‘red’ or long-wave), deutan (‘green’ or middle wave) and tritan (‘blue’ or short-wave)
are used to describe the main colours detected by cones. Colour vision defects usually
manifest as one of three types of abnormality; monochromacy, dichromacy or anomalous
trichromacy respectively referring to the presence of one, two or three functional types of
cone.
Colour vision deficiency (CVD) is one of the commonest disorders of vision, with its causes
being either congenital or acquired. Congenital colour vision defects occur most frequently,
and tend to affect the red-green colour perception. Congenital red-green colour blindness
results from the absence of a single gene on the X chromosome and affects approximately
8% of men and 0.5% of women [1]. Blue-yellow colour blindness is more uncommon and is
caused by an autosomal dominant mutation [2]. Acquired colour vision deficiency is the
consequence of a variety of different ocular insults ranging from disease, trauma and drug
toxicity [3]. The defects seen in congenital CVD affect both eyes equally and the defect
remains consistent throughout a lifetime however acquired defects are usually monocular,
the deficiency is progressive in severity and is often associated with reduced visual acuity
and visual field defects [4,5]. Generally optic nerve lesions are characterized by defective
protan/deutan (red/green) discrimination and retinal lesions by tritan (blue/yellow) defects
[6,7]. Tritan defects are most commonly attributed to acquired causes. Depending on the
extent of the deficiency, patients may be completely unaware of a subtle defect or suffer
from handicap in their day to day activities [8]. Colour vision deficiency impacts many day to
day activities including driving. Although full colour vision is not a legal requirement for
drivers in the UK, one study has linked colour vision deficiency to an increased rate of road
accidents [9].
Colour vision testing (CVT) is performed for a number of reasons including to; quickly screen
for a defect, grade the severity of the defect, diagnose the type of defect or assess the
significance of colour vision deficiency within a particular vocation [4,10]. CVT is often used
as a marker of optic nerve function, alongside visual acuity, visual fields and contrast
sensitivity measurements [11]. Clinical testing of colour vision can be performed through a
variety of different approaches. All should take into account the patients age [12,13], ambient
lighting [14], field size and cognitive issues [15]. One of the most popular methods to test for
red-green CVD is the Ishihara colour vision test [16,17]. Ishihara plates are constructed of
dots of varying hue and size, but similar apparent brightness allowing a normal individual to
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distinguish a coloured numeral against a contrasting background. The abbreviated 24 plate
version consists of 1 control plate, plates 2-9 are transforming numerals, 10-17 are vanishing
numerals, 18-21 are hidden numerals and 22-25 are diagnostic of protan or deutan defects
[18,19]. Figures on transforming plates are read differently by individuals with CVD in
comparison to normal subjects. Only colour normal subjects can recognise the figure on a
vanishing plate and only individuals with CVD can recognise the figure on a hidden plate.
Diagnostic plates differentiate between protan and deutan defects once a patient has been
identified to have a CVD during the screening section of the test. The test is quick to
administer, inexpensive and widely available. Limitations of the Ishihara test are that it fails
to test for tritan defects, protan/deutan defects cannot always be classified and the number
of errors made is not a useful tool to grade the severity of a defect [16,20].
A further popular test is the City University Test which is a derivative of the Farnworth D-15
test, but in book form [21]. The test is divided into two parts: Part A is a screening tool that
consists of triplets of colours, patients are required to state if all spots in each group are the
same. Some triplets are made up of identical spots, but some contain an odd-one-out. Each
plate displays four colour samples surrounding a central spot and the subject must choose
the peripheral colour that resembles the central spot the closest. Each plate provides the
opportunity for a normal response as well as protan, deutan and tritan deficient responses.
The second edition of test is not robust in its differentiation of protan and deutan responses
however the third edition has not yet been validated [16]. This test is useful for identifying
tritan defect and using the number of errors made to grade the severity of a defect [22].
The Mollon-reffin Minimalist Test (MRMT) is a relatively new colour vision test and directly
assesses the patient’s chromatic discrimination along the protan, deutan and tritan confusion
axes. There are six different saturations of the same hue along both the deutan and tritan
axes, and five along the protan axis. The test specifically identifies and classifies the
dichromatic type of inherited colour blindness and is recommended for examination of
acquired CVD. The MRMT identifies all three major forms of CVD and provides an indication
of severity by testing along dichromatic confusion lines which vary in chroma [23].
In the initial development of the MRMT, it was reported to be equivalent to the D-15 colour
vision test for classification of dichromatic defects and able to distinguish between
protanopes and deutanopes [23]. It was thus proposed as suitable for examining acquired
colour vision defects (for detection and monitoring purposes) and reported as a simple test
to administer. The MRMT test was subsequently evaluated in a study of children aged 3 to
10 years and older subjects aged 11 to 39 years and further recommended as useful for
detecting and monitoring acquired colour vision defects in younger age groups. Notably
there was a significant difference found in performance between tests. All children were able
to complete the MRMT test whereas 90% completed the Pease-Allen colour test and 88%
completed the Hardy Rand Rittler test [24]. The MRMT was later compared to the
Farnsworth-Lanthonydesaturated D-15 test in a population of type I diabetic patients with or
without macular oedema. This study found a significant correlation, with high sensitivity and
specificity, between the tritan value of the test and the presence of clinically significant
macular oedema. Conversely the DD-15 test was not significantly correlated, with low
sensitivity for the presence of macular oedema. The difference in performance of the two
tests was attributed to the MRMT test assessing the tritan axis separately and directly along
the confusion line whereas the DD-15 test only identified the confusion axis for blue-yellow
defects. The authors recommended the MRMT as a useful test in the screening and follow-
up examination for macular oedema in young diabetic patients [25].
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The aims of this study are to assess the clinical effectiveness of the MRMT in comparison to
other colour vision tests that are standardly used in our clinical practice in patients attending
routine appointments in general or neurological ophthalmology clinics. We performed this
study to:
 Compare the level of absolute agreement between tests as determined by the
average intraclass correlation coefficient (ICC) for: colour vision defect detection,
colour defect severity grading and identification of particular types of colour vision
defects.
 Compare the time taken to complete each test for all participants in the patient
population and a proportion of the visually normal population.
 Explore the patient group’s experience of each test qualitatively by asking patients
about their perceptions of the tests.
2. MATERIALS AND METHODS
2.1 Visually Normal Population
Fifty-four participants (108 eyes) without any known ophthalmic or neurological pathology
voluntarily took part in this study. None of them complained of any CVD prior to testing. The
visually normal subjects were recruited through the Directorate of Orthoptics and Vision
Science of the University of Liverpool. All three tests were performed consecutively in the
same testing session lasting no more than 20mintues. The tests were completed in random
order to prevent order effects and with a rest time of 3-5 minutes between each test. As
acquired defects have a tendency to affect one eye, all testing was conducted monocularly
by occluding the opposite eye. Twenty participants (40 eyes) were chosen randomly for
retesting on a separate visit following initial assessment.
2.2 Patient Population
One hundred study subjects (197 eyes) were recruited through the Department of
Ophthalmology at Aintree University Hospital. This was a pragmatic clinical study recruiting
patients attending routine ophthalmology appointments. Patients with confirmed posterior
eye disease, such as optic nerve atrophy or papilloedema were identified randomly upon
clinic attendance and invited to take part in the study. Patients who were unable to follow
instructions for performing the test or too ill to complete the assessment were excluded.
Patient demographic details were recorded along with details of clinical diagnosis, level of
visual acuity and if any significant visual field defect was present(>50% field loss). Again all
tests were completed in the same testing session, with test scores and test duration being
recorded for each assessment.  The tests were completed in a set order (1: Ishihara, 2: City,
3: MRMT) and with a rest time of 3-5 minutes between each test. At the end of the testing
session patients were asked “which test did you prefer to complete?” and “which test did you
find the easiest to perform?”
2.3 Ishihara Test
The 24 plate edition (1977) test was used as per standard test protocol. Patients were
shown the test plates at arms length and given 4 seconds to respond to each plate. Misread
plates were viewed for a second time to allow the opportunity to correct the error. Incorrect
responses were recorded when a number was missed or wrongly identified after the second
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attempt.  Normal patients were defined as those with 0 errors. Mild CVD was defined as four
or more incorrect responses [26], moderate deficiency as 5-7 and severe as a score >8.
2.4 City University
The third edition of the test (1998) was used for testing. A normal score for part A would be
10-9, a mild defect would score 8-6, a moderate defect 5-3, and a severe defect 1-2. Defect
severity is also assessed by combining the score obtained in part A with that of part B [27].
2.5 Mollon-reffin
MRMT version 6.0 was the final assessment that participants were asked to complete. The
testing kit comes with nine grey chips, a set of coloured probe chips (6 deutan, 6 tritan and 5
protan) and an orange demonstration chip. The orange demonstration chip is mixed in
amongst five grey chips and the participant is asked to differentiate it from the grey
background chips. One chip would then be selected from the middle of each colour spectrum
and mixed amongst the grey background chips. If successfully identified, then a less
saturated chip would be chosen along the same confusion axis. If unsuccessful, a more
saturated probe chip would then be used. Using the deutan chip set as an example, the least
saturated chip is numbered 1 and the most heavily saturated chip is numbered 6. The
participant would use pointer to identify chips, preventing tarnishing of the chip colours.
Participants with normal colour vision should identify chip 1, in mild deficiency they would
identify 2, in moderate deficiency 3-4 and in severe deficiency chips 5-6 would be identified,
if any at all [23].
2.6 Data Collection and Statistical Analysis
All results were recorded in numerical format to protect subject and patient confidentiality.
SPSS version 20 was used to perform intraclass correlation coefficient analysis to establish
the level of agreement between results. 95% confidence intervals were calculated for all
limits of agreement.
2.7 Ethical Approval
This study received full ethical approval from the National Research Ethics Service, Aintree
University Hospital NHS Foundation Trust and the University of Liverpool.
3. RESULTS AND DISCUSSION
3.1 Study Demographics
The visually normal group consisted of 54 subjects (108 eyes) with a mean age of 25 years
(range 19 to 54). There were 15 males and 39 females. The patient group consisted of 100
subjects (197 eyes) with a mean age of 45 years (range 11 to 90). There were 32 males and
68 females.
Table 1 outlines the clinical characteristics of the study population. The visually normal group
did not report any ophthalmological pathology at the time of testing. The patient group was
noticed to have eight patients with a bilateral visual field defect.
Ajwani et al.; OR, Article no. OR.2014.002
70
Table 1. Demographic and clinical characteristics of the study population
Variable Patient group Visually normal
group
(N=100, 197 eyes) (N=54, 108 eyes)
Diagnosis
 Idiopathic.intracranial
hypertension (iih)
25 N/A
 Space occupying lesion 16 N/A
 Hydrocephalus 7 N/A
 Vascular (infarct/haemorrhage) 4 N/A
 Optic neuropathy 10 N/A
 Other miscellaneous diagnosis 11 N/A
 Unknown 27 N/A
Logmar Visual Acuity (VA) OD OS OD OS
 ≤ 0.0 50 53 50 50
 ≤ 0.5 31 33 4 4
 ≤ 1.0 12 10 0 0
 Hand movements 1 3 0 0
 No perception of light 1 2 0 0
Bilateral Visual Field Defect Present* OD OS OD OS
8 8 0 0
* Visual field defect classified as >50% visual field loss after investigation with perimetry.
OD: Right eye, OS: Left eye
3.2 Colour Vision Defect Detection
The visually normal group statistical analysis shows a strong level of absolute agreement,
ICC value >0.9, when comparing the ability of each test to detect a colour vision defect. The
patient group showed some correlation in the ability of the MRMT to detect defects when
compared to the City test (Fig. 1). The ICC values were 0.77 (95% CI 0.65-0.85) and 0.71
(95% CI 0.56-0.81), for the right and left eyes respectively. The correlation between the
MRMT and the Ishihara test for defect detection was reduced in the right eye, 0.43 (95%CI
0.2-0.65) and of a similar level to the other test for the left eye, 0.71 (95% CI 0.56-0.81).
3.3 Colour Vision Severity of Defect
Participants in the visually normal group did not exhibit any defects on any of the three tests.
In the patient group, correlation between tests for severity agreement was generally
reduced. In comparison to the Ishihara test the ICC value was 0.57 (95%CI 0.35-0.72) and
0.73 (95%CI 0.58-0.82) for the right and left eyes respectively (Fig. 2). Again, the City Test
showed reduced levels of correlation: 0.61 (95%CI 0.40-0.75) for analysis of patient’s right
eyes and 0.50 (95%CI 0.24-0.68) for the left eye analysis.
3.4 Colour Vision Type of Defect
Type of colour vision defect involves the classification of any detected colour vision
deficiencies into a particular defect form, i.e. protan, deutan and tritan. Classifications were
made for the patient group only. The City Test analysis results showed the MRMT to have
an ICC value of 0.72 (95% CI 0.58-0.82) and 0.76 (95% CI 0.64-0.85) for the left and right
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eyes tested in the patient group (Fig. 3). The Ishihara test showed reduced correlation for
the left eyes tested: ICC values of 0.48 (95% CI 0.22-0.66,) and a stronger level of
correlation with the right eyes tested, 0.76 (95% CI 0.63-0.84).
Fig. 1. The level of absolute agreement between tests as determined by the average
intraclass correlation coefficient (ICC) for colour vision defect detection. Error bars
show 95% confidence intervals for each ICC value. (n = number of patients
successfully completing testing with right/left eye).
3.5 Test Duration
Table 2 shows that in both visually normal and patient groups, the Ishihara test on average
was the fastest to complete, taking 57.5s (+/-44.3) in the patient group and 35.9s (+/-35.9) in
the visually normal group. The MRMT was second fastest in the patient group taking 72.5s
(+/-42.8) and marginally slower to the City Test in the visually normal group taking 53.8 (+/-
7.8). The standard deviations of the patient group are much greater due to subjective
differences such as underlying diagnosis and differences in visual acuity, visual field defects
and age.
Table 2. Average time taken for study participants to complete individual tests per eye
in seconds (+/-SD)
Average time:
Patient group (s)
Average time:
Visually normal group (s)
Ishihara test 57.5 (+/-44.3) 35.9 (+/-5.3)
City test 89.1 (+/-50.9) 53.8 (+/-7.8)
Mollon-reffin test 72.5 (+/-42.28) 55.7 (+/-5.5)
S: Seconds
n = 89 n = 86 n = 86 n = 87
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
MRMT Vs Ishihara
Right Eye
MRMT Vs Ishihara Left
Eye
MRMT Vs City Right
Eye
MRMT Vs City Left Eye
I
C
C
Presence of defect
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Fig. 2. The level of absolute agreement between tests as determined by the average
intraclass correlation coefficient (ICC) for defect severity detection. Error bars show
95% confidence intervals for ICC each value. (n = number of patients successfully
completing testing with right/left eye).
3.6 Test Completion
All subjects in the visually normal group were able to complete all three colour vision tests. A
number of subjects in the patient group could not complete all colour vision tests. Seven
failed to complete the Ishihara test, seven failed to complete the City test and three
wereunable to complete the MRMT. These patients typically had visual acuity of worse than
6/60 Snellen/1.0 logMAR and greater than 50% visual field loss bilaterally.
3.7 Patient Preference
Qualitative measures of patient testing experiences were obtained throughout the study.
Ninety percent of patients preferred the MRMT and 97% of patients found the MRMT the
easiest test to complete.
The aim of this study was to directly compare the ability of the MRMT to detect CVD, defect
severity and type of defect firstly in a visually normal cohort and secondly in a patient group
attending routine ophthalmology appointments. The visually normal group showed a high
level of absolute agreement, ICC >0.9, during both initial testing and re-testing.  In the
patient group this first parameter showed a reasonable level of agreement, ICC >0.70,
between the MRMT and right/left eye city comparisons. This is intuitive as they both detect
the same set of defects, specifically acquired tritan defects [23,28]. By contrast, the lowest
level of agreement was observed with the right eye MRMT vs. Ishihara comparison, giving
n = 88 n = 85 n = 86 n = 85
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
MRMT Vs Ishihara
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MRMT Vs Ishihara Left
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Eye
MRMT Vs City Left Eye
I
C
C
Severity of Defect
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an ICC value of only 0.43 (0.20-0.65). Of note here is the fact that eight patients tested
positive for mild defects on the MRMT without showing any defect on the Ishihara test. It is
likely that the ability of the MRMT to detect subtle CVD may have accounted for this
difference. We did not find an explanation as to why this difference was found for the right
eye and not the left eye also. Level of visual acuity, visual field loss or extent of ocular
disease was not more in the right than the left eyes.
Fig. 3. The level of absolute agreement between tests as determined by the average
intraclass correlation coefficient (ICC) for the type of colour vision defect. Error bars
show 95% confidence intervals for ICC each value. (n = number of patients
successfully completing testing with right/left eye)
It is well known that the number of errors made on the Ishihara test is not a reliable indicator
of defect severity [4,29]. We have attempted to utilise this as a means of drawing
comparison between the MRMT and Ishihara for defect severity. Even with this caveat, we
did notice some correlation with the left Ishihara defect severity and the MRMT. However its
ability to detect subtle differences may again account for the reduced correlation levels in the
right eye comparison. The ICC value for both right and left city severity comparisons were
below 0.70. The severity grading itself showed that the City test was identifying a greater
proportion of mild defects when the MRMT was identifying the same patients as normal. As
before, we found no differences in visual acuity, visual field loss or extent of ocular disease
to explain the discrepancies between right and left eye comparisons.
The average ICC value for the type of defect correlation was >0.70 for all comparisons
except MRMT left vs. Ishihara left: for this the value was 0.48 (0.22-0.66). This group had
five tritan defects that will not have been detected by the Isihara test accounting for the
weaker correlation in this comparison.
n = 85 n = 89 n = 85 n = 87
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Aside fromthe diagnostic accuracy of any test, its clinical value is also dependent upon the
amount of time it takes to perform.  Our timing of the tests showed that the Ishihara test was
the quickest in both groups, with little difference between the MRMT and City test in the
visually normal group taking <1 minute to complete on average. The MRMT was quicker on
average in comparison to the City test in the patient group. However the standard deviations
were large due to individual variation. One study by Thyagrajan et al. [30] also showed the
Ishihara to be the quickest to complete. Interestingly the purpose of this group’s study was to
investigate the effect of visual acuity and refractive error on CVT. They found that different
tests vary in their threshold acuity at which the accuracy of test results becomes affected.
McCulley et al. [31] also considered the factor of a threshold acuity.
As declining visual acuity, field loss and CVDs occur alongside one another in many cases
of optic nerve pathology we decided to investigate the impact of visual field defects on ability
to complete testing. We are not aware of any previous work that has looked into this specific
area of CVT. Our patient group included eight subjects with a VA of worse than 6/60 and a
bilateral visual field defect affecting more than 50% of the field. Of this group six patients
were unable to complete both the Ishihara and City test; in contrast all members of this
group were able to complete the MRMT. The Ishihara test requires patients to have a
sufficient visual field to detect the numeral or numerals on each plate, and completion of the
City test is dependent on all triplet dots being in the field of view at the same time.
Conversely, the MRMT only requires patients to be able to identify one relatively large
coloured chip amongst a series of control chips. The larger coloured chips used in the
MRMT may make it the most suitable CVT for patients with moderate to severe visual field
loss which may be impairing performance in other tests.
Qualitative feedback from the patient group on each testing method provides an insight into
the clinical acceptability of the MRMT. The vast majority of patients preferred the MRMT
(90%), and also considered it the easiest task to complete (97%). This is consistent with the
findings of Shute et al. [24] who recommend the test for young children due to its simplicity
and intuitive design. This feature is important as the cognitive capability of a patient and the
complexity of a test should be considered on an individual basis so that they may do as well
as is subjectively possible [32].
4. CONCLUSION
Our study shows a reasonable level of agreement between the MRMT, the Ishihara test and
City test after considering possible confounders for colour defect detection, severity grading
and defect type classification in the patient group. There is a strong level of agreement in the
visually normal group which suggests a high specificity relative to the other tests. The time
taken to perform the MRMT is clinically acceptable in comparison to the City Test. Patients
experiences of the MRMT are positive and the MRMT was preferred to the other tests.
Notably, patients were able to complete the MRMT when unable to complete the Ishihara
and/or City test. This was particularly applicable to the small group with visual field loss. Our
recommendations are that the MRMT test is a useful and simple to administer test for the
detection and monitoring of colour vision defects in general and neurological ophthalmology
clinics and is particularly useful for assessment of patients with a significant visual field
defect. It will serve as a useful addition to the assessment armamentarium in ophthalmology
clinics.
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